25 research outputs found

    Fusing Authentic Learning & Interprofessional Education: Re-imagining human bioscience education through the use of health care HUDDLE's

    No full text
    James Thompson, Kimberly Charlton, Abirami Thirumanickam, Nicole Prideaux, Kenneth Che

    Communication methods used to self-report pain in those with complex communication needs: protocol for a scoping review

    No full text
    The aim of this scoping review is to examine literature to identify what communication methods are being used to allow people with complex communication needs (CCN) to have their own voice to self-report pain

    Profiles of vocalization change in children with autism receiving early intervention

    No full text
    Abstract not availableDavid Trembath, Marleen F. Westerveld, Srinivas Teppala, Abirami Thirumanickam, Rhylee Sulek, Veronica Rose, Madonna Tucker, Jessica Paynter, Orit Hetzroni, Deb Keen, and Giacomo Vivant

    Spoken Language Change in Children on the Autism Spectrum Receiving Community-Based Interventions

    Get PDF
    OnlinePublWe assessed the spoken language of 73 preschool aged children on the autism spectrum receiving community-based early intervention at two time points, approximately 7 months apart. Using the Spoken Language Benchmarks, there was a small non-signifcant change in the proportion of children transitioning from below, to at or above, Phase 3 (word combinations). Using binomial regression, a model comprising seven of nine clinician-proposed child-related predictors explained 64% of the variance. None of the predictors were individually signifcant, although a large efect size (OR=16.71) was observed for children’s baseline rate of communicative acts. The fndings point to substantial unmet clinical need in children with minimal verbal language, but also the relevance of clinician-proposed predictors of their spoken language outcomes.David Trembath, Matt Stainer, Teena Caithness, Cheryl Dissanayake, Valsamma Eapen, Kathryn Fordyce, Veronica Frewer, Grace Frost, Kristelle Hudry, Teresa Iacono, Nicole Mahler, Anne Masi, Jessica Paynter, Katherine Pye, Shannon Quan, Leanne Shellshear, Rebecca Sutherland, Stephanie Sievers, Abirami Thirumanickam, Marleen F. Westerveld, Madonna Tucke

    Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    No full text
    Background: We describe demographic features, treatments and clinical outcomes in the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) COVID-19 cohort, one of the world’s largest international, standardized data sets concerning hospitalized patients. Methods: The data set analysed includes COVID-19 patients hospitalized between January 2020 and January 2022 in 52 countries. We investigated how symptoms on admission, co-morbidities, risk factors and treatments varied by age, sex and other characteristics. We used Cox regression models to investigate associations between demographics, symptoms, co-morbidities and other factors with risk of death, admission to an intensive care unit (ICU) and invasive mechanical ventilation (IMV). Results: Data were available for 689 572 patients with laboratory-confirmed (91.1%) or clinically diagnosed (8.9%) SARS-CoV-2 infection from 52 countries. Age [adjusted hazard ratio per 10 years 1.49 (95% CI 1.48, 1.49)] and male sex [1.23 (1.21, 1.24)] were associated with a higher risk of death. Rates of admission to an ICU and use of IMV increased with age up to age 60 years then dropped. Symptoms, co-morbidities and treatments varied by age and had varied associations with clinical outcomes. The case-fatality ratio varied by country partly due to differences in the clinical characteristics of recruited patients and was on average 21.5%. Conclusions: Age was the strongest determinant of risk of death, with a ~30-fold difference between the oldest and youngest groups; each of the co-morbidities included was associated with up to an almost 2-fold increase in risk. Smoking and obesity were also associated with a higher risk of death. The size of our international database and the standardized data collection method make this study a comprehensive international description of COVID-19 clinical features. Our findings may inform strategies that involve prioritization of patients hospitalized with COVID-19 who have a higher risk of death

    Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

    No full text
    Introduction: Acute kidney injury (AKI) has been identified as one of the most common and significant problems in hospitalized patients with COVID-19. However, studies examining the relationship between COVID-19 and AKI in low- and low-middle income countries (LLMIC) are lacking. Given that AKI is known to carry a higher mortality rate in these countries, it is important to understand differences in this population. Methods: This prospective, observational study examines the AKI incidence and characteristics of 32,210 patients with COVID-19 from 49 countries across all income levels who were admitted to an intensive care unit during their hospital stay. Results: Among patients with COVID-19 admitted to the intensive care unit, AKI incidence was highest in patients in LLMIC, followed by patients in upper-middle income countries (UMIC) and high-income countries (HIC) (53%, 38%, and 30%, respectively), whereas dialysis rates were lowest among patients with AKI from LLMIC and highest among those from HIC (27% vs. 45%). Patients with AKI in LLMIC had the largest proportion of community-acquired AKI (CA-AKI) and highest rate of in-hospital death (79% vs. 54% in HIC and 66% in UMIC). The association between AKI, being from LLMIC and in-hospital death persisted even after adjusting for disease severity. Conclusions: AKI is a particularly devastating complication of COVID-19 among patients from poorer nations where the gaps in accessibility and quality of healthcare delivery have a major impact on patient outcomes

    The value of open-source clinical science in pandemic response: lessons from ISARIC

    No full text
    corecore